USPTO serial 97901438
Serial No. 97901438
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- RIOS, SASHA BOSHART
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with Serial No. 97901438?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Insulin injectors sold filled with insulin; insulin pens, namely, insulin injectors, sold filled with insulin; insulin dosing pens, namely, insulin injectors, sold filled with insulin; insulin syringes in the nature of pen needles for injecting insulin, sold filled with insulin | ACTIVE | — |
| 010 | Medical apparatus and instruments for monitoring and managing diabetes, namely, blood glucose meters, blood ketone meters, biosensors, sensors for measuring analyte concentrations in interstitial fluid, sensors for monitoring analyte levels in interstitial fluid, sensors for monitoring analyte concentrations in bodily fluids, sensors for monitoring analyte levels in bodily fluids, readers for use with sensors for monitoring analyte concentrations, readers for use with sensors for monitoring analyte levels in bodily fluids, applicators for sensors worn by a human, applicators for biosensors worn by a human, insulin injectors, sold empty, insulin pens, namely, insulin injectors, sold empty, insulin dosing pens, namely, insulin injectors, sold empty, insulin pen caps, replacement caps for insulin devices, digital insulin pen caps, insulin pen caps with embedded software for collecting time and dosage data, dosing modules attachable to insulin pens, insulin syringes in the nature of pen needles, sold empty, medical infusion pumps, and insulin pumps; medical devices worn by a human for monitoring glucose, lactate and ketone levels; readers and applicators for use with medical devices worn by a human for monitoring glucose, lactate and ketone levels; medical devices for monitoring biological analytes; readers and applicators for use with medical devices for monitoring biological analytes; sensors for medical use to be worn by a human to gather physiological data; readers and applicators for use with sensors for medical use to be worn by a human to gather physiological data; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for health and medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for health and medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical wellness purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical wellness purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; applicators and readers for use with electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; sensor-based medical apparatus that tracks, gathers, measures, monitors, and determines biological analyte concentrations and analyte data for use in medical analysis; medical apparatus and instruments for use in monitoring and managing glucose, ketone, and lactate levels; medical apparatus and instruments for use in monitoring and managing biological analyte levels in fluids; medical devices, namely, patient monitors and patient sensors for monitoring, measuring, and managing biological analyte concentrations in in bodily fluids in the fields of health, wellness, and nutrition for health and medical purposes; medical apparatus and instruments for determination of analyte concentrations for health and medical purposes; electrochemical sensors that track, gather, measure, monitor, and determine biological analyte concentrations and analyte data for health and medical purposes; electrochemical sensors for determination of analyte concentrations in fluids for medical purposes and applicators and readers for use with such electrochemical sensors for health and medical purposes; glucose meters; ketone meters; medical apparatus for monitoring biological analyte levels in interstitial fluid; continuous glucose monitoring systems featuring electrochemical sensors for determination of glucose concentrations in bodily fluids for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 8, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jul 8, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 8, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 7, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 6, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 6, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 6, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 8, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 13, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 13, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 7, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 12, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 12, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 12, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 12, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 12, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 8, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 8, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 8, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 9, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jan 9, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Oct 9, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 9, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 9, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 25, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 15, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Apr 15, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jan 25, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 19, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 18, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 25, 2023 | NWAP | NEW APPLICATION ENTERED | — |